The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Statement re Dispute with Greencastle

14 Apr 2021 07:00

RNS Number : 3674V
Iconic Labs PLC
14 April 2021
 

14 April 2021

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

 

Dispute with Greencastle Acquisition and others and investigation of former directors' conduct

 

Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business, announces that it has received (i) a statutory demand served by Greencastle Acquisition Limited for an amount (£58,668) alleged to be comprised of various sums assigned by John Quinlan, Liam Harrington and Samuel Regan Asante (the "Former Directors"), David Sefton, Matthew Vincent and Chris Pye less amounts owed by Greencastle entities to Iconic, including a £1,000,000 loan and management services fees; and (ii) a letter of demand from David Sefton claiming the amount of £256,676, allegedly comprising certain unpaid invoices. Such claims, which the Company believes are wholly without merit, will be vigorously defended by the Company in their entirety.

 

The Company has today sent a pre-action letter to Greencastle Acquisition Limited, Greencastle MM LLP, Greencastle Capital Limited, Linton Capital LLP and David Sefton, outlining a number of serious wrongdoings, including breaches of duty. Should the Company not receive a satisfactory response, the Company intends to issue proceedings in the Commercial Court in London.

 

The Company has also appointed forensic accounting and legal experts to assist with its investigation into further allegations of wrongdoing against the Former Directors and David Sefton.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

Iconic Labs ir@iconiclabs.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRDKNBQCBKDDQD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.